logo
logo

Uk Biotech Oxford Nanopore Plans London Ipo, Seeks £300M Funding

Sep 20, 2021•almost 4 years ago

Amount Raised

£300 Million

United Kingdom

Description

DNA-sequencing company Oxford Nanopore Technologies provides rapid COVID-19 tests to the NHS in Britain. Recently, the company announced that it will start trading on the London stock exchange and aims to raise £300 million from Oracle Group, which will increase its valuation to £2.4 billion.

Company Information

Company

Oxford Nanopore

Location

United Kingdom

About

Welcome to Oxford Nanopore technologies. Our goal is to enable the analysis of any living thing, by any person, in any environment. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech